Publications

General

1. Martinowitz U, Spotnitz WD. Fibrin tissue adhesives. Thrombosis and Haemostasis 1997; 78(1): 661-666.
   
2. R W Busuttil. A comparison of anti fibrinolytic agents used in haemostatic fibrin sealants. J AM Coll Surg, Vol. 197, No.6, December 2003
   
3. Wiseman, Nur I. The effect of tranexamic acid in fibrin sealant on adhesion formation in rats. J Biomed Mater Res B Appl Biomater. 2004 Feb, 15; 68(2):222-30
   
4. Paulmier Philippe. Letter to the Editor. Biologicals (2000);28, 55.
   
5. Hendrickx B, DeWulf L, Badhare S, Smith A. Clinical experience with a human surgical sealant (Quixil), a plasma derivative of human origin, in liver and orthopedic surgery. Plasma product biotechnology meeting, Malta, 2001.
   
6. Brodniewiez T. Review of clinical trials to date for major indications for fibrin sealant. Emerging Applications of Tissue Sealants – Europe. Nov. 19-20, Lisbon, Portugal, 1998.
   
7. Lieberman O. Quixil™: enhanced clinical application of a new type of fibrin sealant. Emerging Applications of Tissue Sealant – Europe. Nov. 19-20, Lisbon, Portugal. 1998.
   
8. Nur I, Lushkov G, Lachovetzky Y, Shoshani E. ‘Fibrin Glue” is not a generic product–Hemostasis and adhesion prevention by fibrin vs. cryo-based sealants. XVIth Congress of the International Society on Thrombosis and Haemostasis, Florence, Italy, June, 1997.[Thrombosis and Haemostasis Supplement 1997: p.197].
   
9. Spotnitz W. Fibrin-based tissue adhesives reduce bleeding and promote post-operative healing. American College of Surgeons (ACS), Chicago, Oct. 1997.
   
10. Nur I. The composition of fibrin sealants and their in-vivo activity in animal models. Emerging Applications of Tissue Sealants – Europe. Nov. 19-20, Lisbon, Portugal, 1998.
    
11. Nur I, Paulmier P, Lushkov G, Faure L, Virat M. Evaluation of the absorption of 125I thrombin and 3H tranexamic acid after application of Quixil on hepatic wounds in rabbits. XVIth Congress of the International Society on Thrombosis and Haemostasis, Florence, Italy, June, 1997. [Thrombosis and Hemostasis Supplement 1997: p.251].
    
12. Auletta C, Weiner M, Richter W. A dietary toxicity/oncogenicity study of tributyl phosphate in the rat. Toxicology. 126 1998: 125-134.
    
13. Auletta C, Weiner M, Richter W. A dietary oncogenicity study of tributyl phosphate in CD-1 mouse. Toxicology. 126 1998: 135-141.
    
14. Nur I, Routledge G, Lushkov G, Paulmier P, Virat M. Absorption and elimination of a- thrombin and tranexamic acid after fibrin sealant application on resected livers in rabbits. Blood Coagulation and Fibrinolysis. 1998; 9(6): 533-537.
    
15. Schlag M, Hopf R, Redl H. Convulsive seizures following subdural application of fibrin sealant containing tranexamic acid in a rat model. Neurosurgery. 2000; 47(6): 1463-1467.
    
16. Baru M, Gehringer W, Nur I. The biochemical properties of a new biological adhesive “Octacol”. Thrombosis Haemostasis 1993; 69(6); 944.
    
17. Gehringer W, Stadler M, Biesert L, Nur I, Martinowitz H, Josic D, Schwinn H. Mechanical properties and virus validation of Octacol, a new homologous human tissue adhesive. Fibrin sealant: characteristics and clinical uses. Uniformed Services University of Health and Sciences, Bethesda, Maryland, December 1994
    
18. Gehringer W, Gatner T, Suhartono H, Wang L, Brede HD, Biesert L. Viral safety of a new fibrin glue (Octacol). XVth Congress of the International Society on Thrombosis and Haemostasis, Jerusalem, Israel, June, 1995. [Thrombosis and Haemostasis Supplement 1995; 73(6): p.1470].
    
19. Kuriansky J, Keller N, et al. Antibiotic incorporation into fibrin glue: anti-bacterial properties and dose related inhibitory effect on clot formation. XVth Congress of the International Society on Thrombosis and Haemostasis, Jerusalem, Israel, June, 1995. [Thrombosis and Haemostasis Supplement 1995; 73(6): p.1467].
    
20. Nur I, Baru M, Gehringer W, Stadler M, Schwinn H. A method for testing the intrinsic mechanical properties of fibrin clots commercially available fibrin adhesives. XVth Congress of the International Society on Thrombosis and Haemostasis, Jerusalem, Israel, June, 1995. [Thrombosis and Haemostasis Supplement 1995: p.1472].
    
21. Schwinn H, Stadler M, Gehringer W, Josie D, Biesert L, Nur I. Comparison of biochemical and mechanical properties of human plasma derived fibrin glues. XVth Congress of the International Society on Thrombosis and Haemostasis, Jerusalem, Israel, June, 1995. [Thrombosis and Haemostasis Supplement 1995; 73(6): p.1473].
22. Riera -Kinkel C, Careaga RG, Foyo-Niembro E, Castellanos JE, Castillo M S, Argüero SR. Interaction of indirect myocardial revascularization methods in presence of a fibrin sealant. Experimental Rat model. Abstract/Data on File.
    
23. Baru M, Gerhinger W, Nur I. The Biomehanical Properties of a New Biological Adhesive “OCTACOL”. XIVth Congress of the International Society on Thrombosis and Haemostasis 1993. (same as #69).
    
24. Ali SN, MoiemenNS. Use of Quixil Human Surgical Sealant in Achieving Hemostasis on a Skin Graft Recipient Site of a Fully Heparinized Patient. Plast Recontr Surg. 2006 Jan; 117(1): 339-40
    
25. Nur I, Lyhovetzky Y, Bar L, Schon M. Commercial fibrin sealants are not equivalent in a rabbit liver-resection model which quantitatively evaluates haemostasis and formation of adhesions. Eur Surg Res, 2005 May-June;37(3):159-65.
    
26. Lilliana Bar, Osnat Malka, Elvira Naboichenko and Israel Nur. The binding of fibrin sealant to collagen is influenced by the method of purification and the cross-linked fibrinogen-fibronectin (heteronectin) content of the 'fibrinogen' component. Blood Coagulation & Fibrinolysis 2005, 16:111-117.
    
27. Michael Vaiman MD PhD, Shlomo Sarfaty MD, Nathan Shlamkovich MD, Samuel Segal MD and Ephraim Eviatar MD Fibrin Sealant: Alternative to Nasal Packing in Endonasal Operations. A Prospective Randomized Study. IMAJ 2005; 7:571-574.
    
28. K. Tamaddon,P. Kurzner, A. Aparicio and A.R. Parekh A Suture-Less Approach in Sealing Openings in the Collecting System During Laparoscopic Partial Nephrectomy Using CROSSEAL (Human Fibrin Sealant). Kaiser Permanente Medical Center, West Los Angeles, USA
    
29. Luboshitz J, Berger U, Yaari O, Weissman A, Keidan I, Lalezari S, Goshen G, Moshonov J, Martinowitz U. Autologous Bone and Marrow Grafted Within a Clot of Platelet Rich Plasma Construct Normal Viable Bone. ISTH ABSTRACT 2005